-
1
-
-
42449151214
-
Functions of natural killer cells
-
Vivier, E., E. Tomasello, M. Baratin, T. Walzer, and S. Ugolini. 2008. Functions of natural killer cells. Nat. Immunol. 9: 503-510.
-
(2008)
Nat. Immunol.
, vol.9
, pp. 503-510
-
-
Vivier, E.1
Tomasello, E.2
Baratin, M.3
Walzer, T.4
Ugolini, S.5
-
2
-
-
0036143584
-
What is a natural killer cell?
-
Moretta, A., C. Bottino, M. C. Mingari, R. Biassoni, and L. Moretta. 2002. What is a natural killer cell? Nat. Immunol. 3: 6-8.
-
(2002)
Nat. Immunol.
, vol.3
, pp. 6-8
-
-
Moretta, A.1
Bottino, C.2
Mingari, M.C.3
Biassoni, R.4
Moretta, L.5
-
3
-
-
0036099738
-
Human natural killer cells: Their origin, receptors and function
-
Moretta, L., C. Bottino, D. Pende, M. C. Mingari, R. Biassoni, and A. Moretta. 2002. Human natural killer cells: their origin, receptors and function. Eur. J. Immunol. 32: 1205-1211.
-
(2002)
Eur. J. Immunol.
, vol.32
, pp. 1205-1211
-
-
Moretta, L.1
Bottino, C.2
Pende, D.3
Mingari, M.C.4
Biassoni, R.5
Moretta, A.6
-
5
-
-
0026094467
-
Molecular and functional analysis of human natural killer cell-associated neural cell adhesion molecule (N-CAM/CD56)
-
Lanier, L. L., C. Chang, M. Azuma, J. J. Ruitenberg, J. J. Hemperly, and J. H. Phillips. 1991. Molecular and functional analysis of human natural killer cell-associated neural cell adhesion molecule (N-CAM/CD56). J. Immunol. 146: 4421-4426.
-
(1991)
J. Immunol.
, vol.146
, pp. 4421-4426
-
-
Lanier, L.L.1
Chang, C.2
Azuma, M.3
Ruitenberg, J.J.4
Hemperly, J.J.5
Phillips, J.H.6
-
6
-
-
34948881806
-
Increased natural killer cell expression of CD16, augmented binding and ADCC activity to rituximab among individuals expressing the FcgRIIIa-158 V/V and V/F polymorphism
-
Hatjiharissi, E., L. Xu, D. D. Santos, Z. R. Hunter, B. T. Ciccarelli, S. Verselis, M. Modica, Y. Cao, R. J. Manning, X. Leleu, et al. 2007. Increased natural killer cell expression of CD16, augmented binding and ADCC activity to rituximab among individuals expressing the FcgRIIIa-158 V/V and V/F polymorphism. Blood 110: 2561-2564.
-
(2007)
Blood
, vol.110
, pp. 2561-2564
-
-
Hatjiharissi, E.1
Xu, L.2
Santos, D.D.3
Hunter, Z.R.4
Ciccarelli, B.T.5
Verselis, S.6
Modica, M.7
Cao, Y.8
Manning, R.J.9
Leleu, X.10
-
7
-
-
0035059950
-
Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis
-
Moretta, A., C. Bottino, M. Vitale, D. Pende, C. Cantoni, M. C. Mingari, R. Biassoni, and L. Moretta. 2001. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu. Rev. Immunol. 19: 197-223.
-
(2001)
Annu. Rev. Immunol.
, vol.19
, pp. 197-223
-
-
Moretta, A.1
Bottino, C.2
Vitale, M.3
Pende, D.4
Cantoni, C.5
Mingari, M.C.6
Biassoni, R.7
Moretta, L.8
-
8
-
-
0026753006
-
CD162 CD56+ natural killer cells after bone marrow transplantation
-
Jacobs, R., M. Stoll, G. Stratmann, R. Leo, H. Link, and R. E. Schmidt. 1992. CD162 CD56+ natural killer cells after bone marrow transplantation. Blood 79: 3239-3244.
-
(1992)
Blood
, vol.79
, pp. 3239-3244
-
-
Jacobs, R.1
Stoll, M.2
Stratmann, G.3
Leo, R.4
Link, H.5
Schmidt, R.E.6
-
9
-
-
79952116604
-
CD56bright NK cells after hematopoietic stem cell transplantation are activated mature NK cells that expand in patients with low numbers of T cells
-
Vukicevic, M., Y. Chalandon, C. Helg, T. Matthes, C. Dantin, B. Huard, C. Chizzolini, J. Passweg, and E. Roosnek. 2010. CD56bright NK cells after hematopoietic stem cell transplantation are activated mature NK cells that expand in patients with low numbers of T cells. Eur. J. Immunol. 40: 3246-3254.
-
(2010)
Eur. J. Immunol.
, vol.40
, pp. 3246-3254
-
-
Vukicevic, M.1
Chalandon, Y.2
Helg, C.3
Matthes, T.4
Dantin, C.5
Huard, B.6
Chizzolini, C.7
Passweg, J.8
Roosnek, E.9
-
10
-
-
34247150402
-
CD56brightCD162 killer Ig-like receptor2 NK cells display longer telomeres and acquire features of CD56dim NK cells upon activation
-
Romagnani, C., K. Juelke, M. Falco, B. Morandi, A. D'Agostino, R. Costa, G. Ratto, G. Forte, P. Carrega, G. Lui, et al. 2007. CD56brightCD162 killer Ig-like receptor2 NK cells display longer telomeres and acquire features of CD56dim NK cells upon activation. J. Immunol. 178: 4947-4955.
-
(2007)
J. Immunol.
, vol.178
, pp. 4947-4955
-
-
Romagnani, C.1
Juelke, K.2
Falco, M.3
Morandi, B.4
D'Agostino, A.5
Costa, R.6
Ratto, G.7
Forte, G.8
Carrega, P.9
Lui, G.10
-
11
-
-
77956503431
-
CD62L expression identifies a unique subset of polyfunctional CD56dim NK cells
-
Juelke, K., M. Killig, M. Luetke-Eversloh, E. Parente, J. Gruen, B. Morandi, G. Ferlazzo, A. Thiel, I. Schmitt-Knosalla, and C. Romagnani. 2010. CD62L expression identifies a unique subset of polyfunctional CD56dim NK cells. Blood 116: 1299-1307.
-
(2010)
Blood
, vol.116
, pp. 1299-1307
-
-
Juelke, K.1
Killig, M.2
Luetke-Eversloh, M.3
Parente, E.4
Gruen, J.5
Morandi, B.6
Ferlazzo, G.7
Thiel, A.8
Schmitt-Knosalla, I.9
Romagnani, C.10
-
12
-
-
75649122988
-
CD94 surface density identifies a functional intermediary between the CD56bright and CD56dim human NK-cell subsets
-
Yu, J., H. C. Mao, M. Wei, T. Hughes, J. Zhang, I. K. Park, S. Liu, S. McClory, G. Marcucci, R. Trotta, and M. A. Caligiuri. 2010. CD94 surface density identifies a functional intermediary between the CD56bright and CD56dim human NK-cell subsets. Blood 115: 274-281.
-
(2010)
Blood
, vol.115
, pp. 274-281
-
-
Yu, J.1
Mao, H.C.2
Wei, M.3
Hughes, T.4
Zhang, J.5
Park, I.K.6
Liu, S.7
McClory, S.8
Marcucci, G.9
Trotta, R.10
Caligiuri, M.A.11
-
13
-
-
9144233578
-
Novel insights on human NK cells' immunological modalities revealed by gene expression profiling
-
Hanna, J., P. Bechtel, Y. Zhai, F. Youssef, K. McLachlan, and O. Mandelboim. 2004. Novel insights on human NK cells' immunological modalities revealed by gene expression profiling. J. Immunol. 173: 6547-6563.
-
(2004)
J. Immunol.
, vol.173
, pp. 6547-6563
-
-
Hanna, J.1
Bechtel, P.2
Zhai, Y.3
Youssef, F.4
McLachlan, K.5
Mandelboim, O.6
-
14
-
-
61449115971
-
CD56bright natural killer (NK) cells: An important NK cell subset
-
Poli, A., T. Michel, M. Thérésine, E. Andrès, F. Hentges, and J. Zimmer. 2009. CD56bright natural killer (NK) cells: an important NK cell subset. Immunology 126: 458-465.
-
(2009)
Immunology
, vol.126
, pp. 458-465
-
-
Poli, A.1
Michel, T.2
Thérésine, M.3
Andrès, E.4
Hentges, F.5
Zimmer, J.6
-
15
-
-
34548770748
-
The CD162/CD56bright subset of NK cells is resistant to oxidant-induced cell death
-
Thorén, F. B., A. I. Romero, S. Hermodsson, and K. Hellstrand. 2007. The CD162/CD56bright subset of NK cells is resistant to oxidant-induced cell death. J. Immunol. 179: 781-785.
-
(2007)
J. Immunol.
, vol.179
, pp. 781-785
-
-
Thorén, F.B.1
Romero, A.I.2
Hermodsson, S.3
Hellstrand, K.4
-
16
-
-
3242706150
-
The small subset of CD56brightCD162 natural killer cells is selectively responsible for both cell proliferation and interferon-g production upon interaction with dendritic cells
-
Vitale, M., M. Della Chiesa, S. Carlomagno, C. Romagnani, A. Thiel, L. Moretta, and A. Moretta. 2004. The small subset of CD56brightCD162 natural killer cells is selectively responsible for both cell proliferation and interferon-g production upon interaction with dendritic cells. Eur. J. Immunol. 34: 1715-1722.
-
(2004)
Eur. J. Immunol.
, vol.34
, pp. 1715-1722
-
-
Vitale, M.1
Della Chiesa, M.2
Carlomagno, S.3
Romagnani, C.4
Thiel, A.5
Moretta, L.6
Moretta, A.7
-
17
-
-
78149439385
-
CD57 defines a functionally distinct population of mature NK cells in the human CD56dim CD16+ NK-cell subset
-
Lopez-Vergès, S., J. M. Milush, S. Pandey, V. A. York, J. Arakawa-Hoyt, H. Pircher, P. J. Norris, D. F. Nixon, and L. L. Lanier. 2010. CD57 defines a functionally distinct population of mature NK cells in the human CD56dim CD16+ NK-cell subset. Blood 116: 3865-3874.
-
(2010)
Blood
, vol.116
, pp. 3865-3874
-
-
Lopez-Vergès, S.1
Milush, J.M.2
Pandey, S.3
York, V.A.4
Arakawa-Hoyt, J.5
Pircher, H.6
Norris, P.J.7
Nixon, D.F.8
Lanier, L.L.9
-
18
-
-
77957779206
-
NK cell terminal differentiation: Correlated stepwise decrease of NKG2A and acquisition of KIRs
-
Béziat, V., B. Descours, C. Parizot, P. Debré, and V. Vieillard. 2010. NK cell terminal differentiation: correlated stepwise decrease of NKG2A and acquisition of KIRs. PLoS ONE 5: e11966.
-
(2010)
PLoS ONE
, vol.5
-
-
Béziat, V.1
Descours, B.2
Parizot, C.3
Debré, P.4
Vieillard, V.5
-
19
-
-
78149419031
-
Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education
-
Björkström, N. K., P. Riese, F. Heuts, S. Andersson, C. Fauriat, M. A. Ivarsson, A. T. Björklund, M. Flodström-Tullberg, J. Michaëlsson, M. E. Rottenberg, et al. 2010. Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education. Blood 116: 3853-3864.
-
(2010)
Blood
, vol.116
, pp. 3853-3864
-
-
Björkström, N.K.1
Riese, P.2
Heuts, F.3
Andersson, S.4
Fauriat, C.5
Ivarsson, M.A.6
Björklund, A.T.7
Flodström-Tullberg, M.8
Michaëlsson, J.9
Rottenberg, M.E.10
-
20
-
-
27744464537
-
Sequential deregulation of NK cell subset distribution and function starting in acute HIV-1 infection
-
Alter, G., N. Teigen, B. T. Davis, M. M. Addo, T. J. Suscovich, M. T. Waring, H. Streeck, M. N. Johnston, K. D. Staller, M. T. Zaman, et al. 2005. Sequential deregulation of NK cell subset distribution and function starting in acute HIV-1 infection. Blood 106: 3366-3369.
-
(2005)
Blood
, vol.106
, pp. 3366-3369
-
-
Alter, G.1
Teigen, N.2
Davis, B.T.3
Addo, M.M.4
Suscovich, T.J.5
Waring, M.T.6
Streeck, H.7
Johnston, M.N.8
Staller, K.D.9
Zaman, M.T.10
-
21
-
-
48249137638
-
Altered natural killer cell subset distributions in resolved and persistent hepatitis C virus infection following single source exposure
-
Golden-Mason, L., L. Madrigal-Estebas, E. McGrath, M. J. Conroy, E. J. Ryan, J. E. Hegarty, C. O'Farrelly, and D. G. Doherty. 2008. Altered natural killer cell subset distributions in resolved and persistent hepatitis C virus infection following single source exposure. Gut 57: 1121-1128.
-
(2008)
Gut
, vol.57
, pp. 1121-1128
-
-
Golden-Mason, L.1
Madrigal-Estebas, L.2
McGrath, E.3
Conroy, M.J.4
Ryan, E.J.5
Hegarty, J.E.6
O'Farrelly, C.7
Doherty, D.G.8
-
22
-
-
77949381825
-
Increased proportion of the CD56bright NK cell subset in patients chronically infected with hepatitis C virus (HCV) receiving interferon-a and ribavirin therapy
-
Lee, S., M. W. Watson, J. P. Flexman, W. Cheng, T. Hammond, and P. Price. 2010. Increased proportion of the CD56bright NK cell subset in patients chronically infected with hepatitis C virus (HCV) receiving interferon-a and ribavirin therapy. J. Med. Virol. 82: 568-574.
-
(2010)
J. Med. Virol.
, vol.82
, pp. 568-574
-
-
Lee, S.1
Watson, M.W.2
Flexman, J.P.3
Cheng, W.4
Hammond, T.5
Price, P.6
-
23
-
-
58149217118
-
Increased frequency of CD56Bright NK-cells, CD32CD16+CD562 NK-cells and activated CD4+T-cells or B-cells in parallel with CD4+CDC25High T-cells control potentially viremia in blood donors with HCV
-
Zarife, M. A., E. A. Reis, T. M. Carmo, G. B. Lopes, E. C. Brandão, H. R. Silva, N. Santana, O. A. Martins-Filho, and M. G. Reis. 2009. Increased frequency of CD56Bright NK-cells, CD32CD16+CD562 NK-cells and activated CD4+T-cells or B-cells in parallel with CD4+CDC25High T-cells control potentially viremia in blood donors with HCV. J. Med. Virol. 81: 49-59.
-
(2009)
J. Med. Virol.
, vol.81
, pp. 49-59
-
-
Zarife, M.A.1
Reis, E.A.2
Carmo, T.M.3
Lopes, G.B.4
Brandão, E.C.5
Silva, H.R.6
Santana, N.7
Martins-Filho, O.A.8
Reis, M.G.9
-
24
-
-
20044391050
-
Characterization of CD562/CD16+ natural killer (NK) cells: A highly dysfunctional NK subset expanded in HIV-infected viremic individuals
-
Mavilio, D., G. Lombardo, J. Benjamin, D. Kim, D. Follman, E. Marcenaro, M. A. O'Shea, A. Kinter, C. Kovacs, A. Moretta, and A. S. Fauci. 2005. Characterization of CD562/CD16+ natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals. Proc. Natl. Acad. Sci. USA 102: 2886-2891.
-
(2005)
Proc. Natl. Acad. Sci. USA
, vol.102
, pp. 2886-2891
-
-
Mavilio, D.1
Lombardo, G.2
Benjamin, J.3
Kim, D.4
Follman, D.5
Marcenaro, E.6
O'Shea, M.A.7
Kinter, A.8
Kovacs, C.9
Moretta, A.10
Fauci, A.S.11
-
25
-
-
0031572260
-
Cord blood CD16+562 cells with low lytic activity are possible precursors of mature natural killer cells
-
Gaddy, J., and H. E. Broxmeyer. 1997. Cord blood CD16+562 cells with low lytic activity are possible precursors of mature natural killer cells. Cell. Immunol. 180: 132-142.
-
(1997)
Cell. Immunol.
, vol.180
, pp. 132-142
-
-
Gaddy, J.1
Broxmeyer, H.E.2
-
26
-
-
33846619756
-
Induction of CD16+ CD56bright NK cells with antitumour cytotoxicity not only from CD162 CD56bright NK cells but also from CD162 CD56dim NK cells
-
Takahashi, E., N. Kuranaga, K. Satoh, Y. Habu, N. Shinomiya, T. Asano, S. Seki, and M. Hayakawa. 2007. Induction of CD16+ CD56bright NK cells with antitumour cytotoxicity not only from CD162 CD56bright NK cells but also from CD162 CD56dim NK cells. Scand. J. Immunol. 65: 126-138.
-
(2007)
Scand. J. Immunol.
, vol.65
, pp. 126-138
-
-
Takahashi, E.1
Kuranaga, N.2
Satoh, K.3
Habu, Y.4
Shinomiya, N.5
Asano, T.6
Seki, S.7
Hayakawa, M.8
-
27
-
-
33646877669
-
Human natural killer cell development and biology
-
Farag, S. S., and M. A. Caligiuri. 2006. Human natural killer cell development and biology. Blood Rev. 20: 123-137.
-
(2006)
Blood Rev.
, vol.20
, pp. 123-137
-
-
Farag, S.S.1
Caligiuri, M.A.2
-
28
-
-
33750686595
-
Human natural killer cell development
-
Freud, A. G., and M. A. Caligiuri. 2006. Human natural killer cell development. Immunol. Rev. 214: 56-72.
-
(2006)
Immunol. Rev.
, vol.214
, pp. 56-72
-
-
Freud, A.G.1
Caligiuri, M.A.2
-
29
-
-
33645839311
-
Evidence for discrete stages of human natural killer cell differentiation in vivo
-
Freud, A. G., A. Yokohama, B. Becknell, M. T. Lee, H. C. Mao, A. K. Ferketich, and M. A. Caligiuri. 2006. Evidence for discrete stages of human natural killer cell differentiation in vivo. J. Exp. Med. 203: 1033-1043.
-
(2006)
J. Exp. Med.
, vol.203
, pp. 1033-1043
-
-
Freud, A.G.1
Yokohama, A.2
Becknell, B.3
Lee, M.T.4
Mao, H.C.5
Ferketich, A.K.6
Caligiuri, M.A.7
-
30
-
-
77957803871
-
Human NK cells display major phenotypic and functional changes over the life span
-
Le Garff-Tavernier, M., V. Béziat, J. Decocq, V. Siguret, F. Gandjbakhch, E. Pautas, P. Debré, H. Merle-Beral, and V. Vieillard. 2010. Human NK cells display major phenotypic and functional changes over the life span. Aging Cell 9: 527-535.
-
(2010)
Aging Cell
, vol.9
, pp. 527-535
-
-
Le Garff-Tavernier, M.1
Béziat, V.2
Decocq, J.3
Siguret, V.4
Gandjbakhch, F.5
Pautas, E.6
Debré, P.7
Merle-Beral, H.8
Vieillard, V.9
-
31
-
-
8644265838
-
Evidence for immune defects in breast and lung cancer patients
-
Caras, I., A. Grigorescu, C. Stavaru, D. L. Radu, I. Mogos, G. Szegli, and A. Salageanu. 2004. Evidence for immune defects in breast and lung cancer patients. Cancer Immunol. Immunother. 53: 1146-1152.
-
(2004)
Cancer Immunol. Immunother.
, vol.53
, pp. 1146-1152
-
-
Caras, I.1
Grigorescu, A.2
Stavaru, C.3
Radu, D.L.4
Mogos, I.5
Szegli, G.6
Salageanu, A.7
-
32
-
-
80052346280
-
Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity
-
Mamessier, E., A. Sylvain, M. L. Thibult, G. Houvenaeghel, J. Jacquemier, R. Castellano, A. Gonçalves, P. André, F. Romagné, G. Thibault, et al. 2011. Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity. J. Clin. Invest. 121: 3609-3622.
-
(2011)
J. Clin. Invest.
, vol.121
, pp. 3609-3622
-
-
Mamessier, E.1
Sylvain, A.2
Thibult, M.L.3
Houvenaeghel, G.4
Jacquemier, J.5
Castellano, R.6
Gonçalves, A.7
André, P.8
Romagné, F.9
Thibault, G.10
-
33
-
-
80155132470
-
Human breast tumor cells induce self-tolerance mechanisms to avoid NKG2D-mediated and DNAM-mediated NK cell recognition
-
Mamessier, E., A. Sylvain, F. Bertucci, R. Castellano, P. Finetti, G. Houvenaeghel, E. Charaffe-Jaufret, D. Birnbaum, A. Moretta, and D. Olive. 2011. Human breast tumor cells induce self-tolerance mechanisms to avoid NKG2D-mediated and DNAM-mediated NK cell recognition. Cancer Res. 71: 6621-6632.
-
(2011)
Cancer Res.
, vol.71
, pp. 6621-6632
-
-
Mamessier, E.1
Sylvain, A.2
Bertucci, F.3
Castellano, R.4
Finetti, P.5
Houvenaeghel, G.6
Charaffe-Jaufret, E.7
Birnbaum, D.8
Moretta, A.9
Olive, D.10
-
34
-
-
1642275490
-
Analysis of the activating receptors and cytolytic function of human natural killer cells undergoing in vivo differentiation after allogeneic bone marrow transplantation
-
Vitale, C., L. Chiossone, G. Morreale, E. Lanino, F. Cottalasso, S. Moretti, G. Dini, L. Moretta, and M. C. Mingari. 2004. Analysis of the activating receptors and cytolytic function of human natural killer cells undergoing in vivo differentiation after allogeneic bone marrow transplantation. Eur. J. Immunol. 34: 455-460.
-
(2004)
Eur. J. Immunol.
, vol.34
, pp. 455-460
-
-
Vitale, C.1
Chiossone, L.2
Morreale, G.3
Lanino, E.4
Cottalasso, F.5
Moretti, S.6
Dini, G.7
Moretta, L.8
Mingari, M.C.9
-
35
-
-
1642485249
-
The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic
-
Ferlazzo, G., D. Thomas, S. L. Lin, K. Goodman, B. Morandi, W. A. Muller, A. Moretta, and C. Münz. 2004. The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic. J. Immunol. 172: 1455-1462.
-
(2004)
J. Immunol.
, vol.172
, pp. 1455-1462
-
-
Ferlazzo, G.1
Thomas, D.2
Lin, S.L.3
Goodman, K.4
Morandi, B.5
Muller, W.A.6
Moretta, A.7
Münz, C.8
-
36
-
-
33748865886
-
NK cells of human secondary lymphoid tissues enhance T cell polarization via IFN-g secretion
-
Morandi, B., G. Bougras, W. A. Muller, G. Ferlazzo, and C. Münz. 2006. NK cells of human secondary lymphoid tissues enhance T cell polarization via IFN-g secretion. Eur. J. Immunol. 36: 2394-2400.
-
(2006)
Eur. J. Immunol.
, vol.36
, pp. 2394-2400
-
-
Morandi, B.1
Bougras, G.2
Muller, W.A.3
Ferlazzo, G.4
Münz, C.5
-
37
-
-
0024206753
-
Specific lysis of allogeneic cells after activation of CD32 lymphocytes in mixed lymphocyte culture
-
Ciccone, E., O. Viale, D. Pende, M. Malnati, R. Biassoni, G. Melioli, A. Moretta, E. O. Long, and L. Moretta. 1988. Specific lysis of allogeneic cells after activation of CD32 lymphocytes in mixed lymphocyte culture. J. Exp. Med. 168: 2403-2408.
-
(1988)
J. Exp. Med.
, vol.168
, pp. 2403-2408
-
-
Ciccone, E.1
Viale, O.2
Pende, D.3
Malnati, M.4
Biassoni, R.5
Melioli, G.6
Moretta, A.7
Long, E.O.8
Moretta, L.9
-
38
-
-
0023203185
-
Confirmation of a prognostic index in primary breast cancer
-
Todd, J. H., C. Dowle, M. R. Williams, C. W. Elston, I. O. Ellis, C. P. Hinton, R. W. Blamey, and J. L. Haybittle. 1987. Confirmation of a prognostic index in primary breast cancer. Br. J. Cancer 56: 489-492.
-
(1987)
Br. J. Cancer
, vol.56
, pp. 489-492
-
-
Todd, J.H.1
Dowle, C.2
Williams, M.R.3
Elston, C.W.4
Ellis, I.O.5
Hinton, C.P.6
Blamey, R.W.7
Haybittle, J.L.8
-
39
-
-
79954494822
-
Revisited function of human NK cell subsets
-
De Maria, A., and L. Moretta. 2011. Revisited function of human NK cell subsets. Cell Cycle 10: 1178-1179.
-
(2011)
Cell Cycle
, vol.10
, pp. 1178-1179
-
-
De Maria, A.1
Moretta, L.2
-
40
-
-
0035125541
-
The phenotypic heterogeneity of human natural killer cells: Presence of at least 48 different subsets in the peripheral blood
-
Jonges, L. E., P. Albertsson, R. L. van Vlierberghe, N. G. Ensink, B. R. Johansson, C. J. van de Velde, G. J. Fleuren, U. Nannmark, and P. J. Kuppen. 2001. The phenotypic heterogeneity of human natural killer cells: presence of at least 48 different subsets in the peripheral blood. Scand. J. Immunol. 53: 103-110.
-
(2001)
Scand. J. Immunol.
, vol.53
, pp. 103-110
-
-
Jonges, L.E.1
Albertsson, P.2
Van Vlierberghe, R.L.3
Ensink, N.G.4
Johansson, B.R.5
Velde De Van, C.J.6
Fleuren, G.J.7
Nannmark, U.8
Kuppen, P.J.9
-
41
-
-
34250802584
-
CD56bright human NK cells differentiate into CD56dim cells: Role of contact with peripheral fibroblasts
-
Chan, A., D. L. Hong, A. Atzberger, S. Kollnberger, A. D. Filer, C. D. Buckley, A. McMichael, T. Enver, and P. Bowness. 2007. CD56bright human NK cells differentiate into CD56dim cells: role of contact with peripheral fibroblasts. J. Immunol. 179: 89-94.
-
(2007)
J. Immunol.
, vol.179
, pp. 89-94
-
-
Chan, A.1
Hong, D.L.2
Atzberger, A.3
Kollnberger, S.4
Filer, A.D.5
Buckley, C.D.6
McMichael, A.7
Enver, T.8
Bowness, P.9
-
42
-
-
49649107807
-
An unusual CD56bright CD16low NK cell subset dominates the early posttransplant period following HLAmatched hematopoietic stem cell transplantation
-
Dulphy, N., P. Haas, M. Busson, S. Belhadj, R. Peffault de Latour, M. Robin, M. Carmagnat, P. Loiseau, R. Tamouza, C. Scieux, et al. 2008. An unusual CD56bright CD16low NK cell subset dominates the early posttransplant period following HLAmatched hematopoietic stem cell transplantation. J. Immunol. 181: 2227-2237.
-
(2008)
J. Immunol.
, vol.181
, pp. 2227-2237
-
-
Dulphy, N.1
Haas, P.2
Busson, M.3
Belhadj, S.4
Latour De R.Peffault5
Robin, M.6
Carmagnat, M.7
Loiseau, P.8
Tamouza, R.9
Scieux, C.10
-
43
-
-
79959552147
-
CD56brightCD16+ NK cells: A functional intermediate stage of NK cell differentiation
-
Béziat, V., D. Duffy, S. N. Quoc, M. Le Garff-Tavernier, J. Decocq, B. Combadière, P. Debré, and V. Vieillard. 2011. CD56brightCD16+ NK cells: a functional intermediate stage of NK cell differentiation. J. Immunol. 186: 6753-6761.
-
(2011)
J. Immunol.
, vol.186
, pp. 6753-6761
-
-
Béziat, V.1
Duffy, D.2
Quoc, S.N.3
Le Garff-Tavernier, M.4
Decocq, J.5
Combadière, B.6
Debré, P.7
Vieillard, V.8
-
44
-
-
0036486763
-
Role of chemokines in the biology of natural killer cells
-
Robertson, M. J. 2002. Role of chemokines in the biology of natural killer cells. J. Leukoc. Biol. 71: 173-183.
-
(2002)
J. Leukoc. Biol.
, vol.71
, pp. 173-183
-
-
Robertson, M.J.1
-
45
-
-
45449120864
-
CD16+ CD562 NK cells in the peripheral blood of cord blood transplant recipients: A unique subset of NK cells possibly associated with graft-versus-leukemia effect
-
Lu, X., Y. Kondo, H. Takamatsu, K. Ohata, H. Yamazaki, A. Takami, Y. Akatsuka, and S. Nakao. 2008. CD16+ CD562 NK cells in the peripheral blood of cord blood transplant recipients: a unique subset of NK cells possibly associated with graft-versus-leukemia effect. Eur. J. Haematol. 81: 18-25.
-
(2008)
Eur. J. Haematol.
, vol.81
, pp. 18-25
-
-
Lu, X.1
Kondo, Y.2
Takamatsu, H.3
Ohata, K.4
Yamazaki, H.5
Takami, A.6
Akatsuka, Y.7
Nakao, S.8
-
46
-
-
77956111335
-
TGF-b affects development and differentiation of human natural killer cell subsets
-
Allan, D. S., B. Rybalov, G. Awong, J. C. Zúñiga- Pflücker, H. D. Kopcow, J. R. Carlyle, and J. L. Strominger. 2010. TGF-b affects development and differentiation of human natural killer cell subsets. Eur. J. Immunol. 40: 2289-2295.
-
(2010)
Eur. J. Immunol.
, vol.40
, pp. 2289-2295
-
-
Allan, D.S.1
Rybalov, B.2
Awong, G.3
Zúñiga-Pflücker, J.C.4
Kopcow, H.D.5
Carlyle, J.R.6
Strominger, J.L.7
-
47
-
-
79955112454
-
Expansion of CD16-negative natural killer cells in the peripheral blood of patients with metastatic melanoma
-
Holtan, S. G., D. J. Creedon, M. A. Thompson, W. K. Nevala, and S. N. Markovic. 2011. Expansion of CD16-negative natural killer cells in the peripheral blood of patients with metastatic melanoma. Clin. Dev. Immunol. 2011: 316314.
-
(2011)
Clin. Dev. Immunol.
, vol.2011
, pp. 316314
-
-
Holtan, S.G.1
Creedon, D.J.2
Thompson, M.A.3
Nevala, W.K.4
Markovic, S.N.5
-
48
-
-
0034741083
-
TGF-b1 is elevated in breast cancer tissue and regulates nitric oxide production from a number of cellular sources during hypoxia re-oxygenation injury
-
Toomey, D., C. Condron, Q. D. Wu, E. Kay, J. Harmey, P. Broe, C. Kelly, and D. Bouchier-Hayes. 2001. TGF-b1 is elevated in breast cancer tissue and regulates nitric oxide production from a number of cellular sources during hypoxia re-oxygenation injury. Br. J. Biomed. Sci. 58: 177-183.
-
(2001)
Br. J. Biomed. Sci.
, vol.58
, pp. 177-183
-
-
Toomey, D.1
Condron, C.2
Wu, Q.D.3
Kay, E.4
Harmey, J.5
Broe, P.6
Kelly, C.7
Bouchier-Hayes, D.8
-
49
-
-
0037363281
-
Elevated plasma levels of transforming growth factor-b1 (TGF-b1) in patients with advanced breast cancer: Association with disease progression
-
Ivanović, V., N. Todorović-Raković, M. Demajo, Z. Nesković-Konstantinović, V. Subota, O. Ivanisević- Milovanović, and D. Nikolić-Vukosavljević. 2003. Elevated plasma levels of transforming growth factor-b1 (TGF-b1) in patients with advanced breast cancer: association with disease progression. Eur. J. Cancer 39: 454-461.
-
(2003)
Eur. J. Cancer
, vol.39
, pp. 454-461
-
-
Ivanović, V.1
Todorović-Raković, N.2
Demajo, M.3
Nesković-Konstantinović, Z.4
Subota, V.5
Ivanisević- Milovanović, O.6
Nikolić-Vukosavljević, D.7
-
50
-
-
39049139508
-
Natural killer cells infiltrating human nonsmall-cell lung cancer are enriched in CD56bright CD162 cells and display an impaired capability to kill tumor cells
-
Carrega, P., B. Morandi, R. Costa, G. Frumento, G. Forte, G. Altavilla, G. B. Ratto, M. C. Mingari, L. Moretta, and G. Ferlazzo. 2008. Natural killer cells infiltrating human nonsmall-cell lung cancer are enriched in CD56bright CD162 cells and display an impaired capability to kill tumor cells. Cancer 112: 863-875.
-
(2008)
Cancer
, vol.112
, pp. 863-875
-
-
Carrega, P.1
Morandi, B.2
Costa, R.3
Frumento, G.4
Forte, G.5
Altavilla, G.6
Ratto, G.B.7
Mingari, M.C.8
Moretta, L.9
Ferlazzo, G.10
-
51
-
-
0037208228
-
Preferential apoptosis of CD56dim natural killer cell subset in patients with cancer
-
Bauernhofer, T., I. Kuss, B. Henderson, A. S. Baum, and T. L. Whiteside. 2003. Preferential apoptosis of CD56dim natural killer cell subset in patients with cancer. Eur. J. Immunol. 33: 119-124.
-
(2003)
Eur. J. Immunol.
, vol.33
, pp. 119-124
-
-
Bauernhofer, T.1
Kuss, I.2
Henderson, B.3
Baum, A.S.4
Whiteside, T.L.5
-
52
-
-
2142696747
-
Localization of recognition site between transforming growth factor-b1 (TGF-b1) and TGFb receptor type II: Possible implications in breast cancer
-
Ivanović, V., M. Demajo, N. Todorović-Raković, D. Nikolić-Vukosavljević, Z. Nesković-Konstantinović, K. Krtolica, V. Veljković, J. Prljić, and B. Dimitrijević. 2004. Localization of recognition site between transforming growth factor-b1 (TGF-b1) and TGFb receptor type II: possible implications in breast cancer. Med. Hypotheses 62: 727-732.
-
(2004)
Med. Hypotheses
, vol.62
, pp. 727-732
-
-
Ivanović, V.1
Demajo, M.2
Todorović-Raković, N.3
Nikolić-Vukosavljević, D.4
Nesković-Konstantinović, Z.5
Krtolica, K.6
Veljković, V.7
Prljić, J.8
Dimitrijević, B.9
-
53
-
-
9344263448
-
Distinct roles of IL- 12 and IL-15 in human natural killer cell activation by dendritic cells from secondary lymphoid organs
-
Ferlazzo, G., M. Pack, D. Thomas, C. Paludan, D. Schmid, T. Strowig, G. Bougras, W. A. Muller, L. Moretta, and C. Münz. 2004. Distinct roles of IL- 12 and IL-15 in human natural killer cell activation by dendritic cells from secondary lymphoid organs. Proc. Natl. Acad. Sci. USA 101: 16606-16611.
-
(2004)
Proc. Natl. Acad. Sci. USA
, vol.101
, pp. 16606-16611
-
-
Ferlazzo, G.1
Pack, M.2
Thomas, D.3
Paludan, C.4
Schmid, D.5
Strowig, T.6
Bougras, G.7
Muller, W.A.8
Moretta, L.9
Münz, C.10
-
54
-
-
79951695881
-
Homeostatic proliferation generates long-lived natural killer cells that respond against viral infection
-
Sun, J. C., J. N. Beilke, N. A. Bezman, and L. L. Lanier. 2011. Homeostatic proliferation generates long-lived natural killer cells that respond against viral infection. J. Exp. Med. 208: 357-368.
-
(2011)
J. Exp. Med.
, vol.208
, pp. 357-368
-
-
Sun, J.C.1
Beilke, J.N.2
Bezman, N.A.3
Lanier, L.L.4
-
55
-
-
77957724586
-
MHC class I-deficient natural killer cells acquire a licensed phenotype after transfer into an MHC class I-sufficient environment
-
Elliott, J. M., J. A. Wahle, and W. M. Yokoyama. 2010. MHC class I-deficient natural killer cells acquire a licensed phenotype after transfer into an MHC class I-sufficient environment. J. Exp. Med. 207: 2073-2079.
-
(2010)
J. Exp. Med.
, vol.207
, pp. 2073-2079
-
-
Elliott, J.M.1
Wahle, J.A.2
Yokoyama, W.M.3
-
56
-
-
77957747686
-
Mature natural killer cells reset their responsiveness when exposed to an altered MHC environment
-
Joncker, N. T., N. Shifrin, F. Delebecque, and D. H. Raulet. 2010. Mature natural killer cells reset their responsiveness when exposed to an altered MHC environment. J. Exp. Med. 207: 2065-2072.
-
(2010)
J. Exp. Med.
, vol.207
, pp. 2065-2072
-
-
Joncker, N.T.1
Shifrin, N.2
Delebecque, F.3
Raulet, D.H.4
-
57
-
-
78049252250
-
CD56 negative NK cells: Origin, function, and role in chronic viral disease
-
Björkström, N. K., H. G. Ljunggren, and J. K. Sandberg. 2010. CD56 negative NK cells: origin, function, and role in chronic viral disease. Trends Immunol. 31: 401-406.
-
(2010)
Trends Immunol.
, vol.31
, pp. 401-406
-
-
Björkström, N.K.1
Ljunggren, H.G.2
Sandberg, J.K.3
-
58
-
-
60449110935
-
Natural killer cell tolerance licensing and other mechanisms
-
Jonsson, A. H., and W. M. Yokoyama. 2009. Natural killer cell tolerance licensing and other mechanisms. Adv. Immunol. 101: 27-79.
-
(2009)
Adv. Immunol.
, vol.101
, pp. 27-79
-
-
Jonsson, A.H.1
Yokoyama, W.M.2
-
59
-
-
77957747156
-
Re-educating natural killer cells
-
Sun, J. C. 2010. Re-educating natural killer cells. J. Exp. Med. 207: 2049-2052.
-
(2010)
J. Exp. Med.
, vol.207
, pp. 2049-2052
-
-
Sun, J.C.1
-
60
-
-
0037606040
-
CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: A potential new link between adaptive and innate immunity
-
Fehniger, T. A., M. A. Cooper, G. J. Nuovo, M. Cella, F. Facchetti, M. Colonna, and M. A. Caligiuri. 2003. CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity. Blood 101: 3052-3057.
-
(2003)
Blood
, vol.101
, pp. 3052-3057
-
-
Fehniger, T.A.1
Cooper, M.A.2
Nuovo, G.J.3
Cella, M.4
Facchetti, F.5
Colonna, M.6
Caligiuri, M.A.7
|